Novel Therapeutics for Rare Lymphomas

Overview of attention for book

Cover of 'Novel Therapeutics for Rare Lymphomas'

Table of Contents

Altmetric Badge

Book Overview
Altmetric Badge

Chapter 2 Novel Therapeutics in the Management of Waldenström Macroglobulinemia
Altmetric Badge

Chapter 3 Immunotherapy in Hodgkin Lymphoma and Other CD30+ Lymphomas
Altmetric Badge

Chapter 4 Chronic Lymphocytic Leukemia with Alterations in TP53
Altmetric Badge

Chapter 6 Current and Emerging Treatment Strategies for Primary Mediastinal B-Cell Lymphoma
Altmetric Badge

Chapter 7 Plasmablastic Lymphoma and Primary Effusion Lymphoma
Altmetric Badge

Chapter 9 Adult T-Cell Leukemia/Lymphoma
Altmetric Badge

Chapter 13 Hepatosplenic T-Cell Lymphoma
Altmetric Badge

Chapter 14 Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sézary Syndrome

Attention for Chapter 2: Novel Therapeutics in the Management of Waldenström Macroglobulinemia

Altmetric Badge

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham’s Lymphangiomatosis: Review of the Literature

Article in Case Reports in Hematology (June 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.